VoneshE.F.Membrane transport models and computerized kinetic modeling applied to automated peritoneal dialysis.Contrib Nephrol1999; 129: 15–34.
5.
DemetriouD., HabichtA., SchillingerM., HörlW.H., VychytilA.Adequacy of automated peritoneal dialysis with and without manual daytime exchange: a randomized, controlled trial.Kidney Int2006; 70: 1649–55.
6.
FusshollerA., NiedenS.Z., GrabenseeB., PlumJ.Peritoneal fluid and solute transport: influence of treatment time, peritoneal dialysis modality and peritonitis incidence.J Am Soc Nephrol2002; 13: 1055–60.
7.
DaviesS.J., BrownE.A., FrandsenN.E., RodriguesA., Rodríguez-CarmonaA., VychytilA.Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription.Kidney Int2005; 67: 1609–15.
8.
Rodríguez-CarmonaA., Pérez-FontánM.Sodium removal in patients undergoing CAPD and automated peritoneal dialysis patients.Perit Dial Int2002; 22: 705–13.
SelbyN.M., FonsecaS., HulmeL., FluckR.J., TaalM.W., McIntyreC.W.Automated peritoneal dialysis has significant effects on systemic hemodynamics.Perit Dial Int2006; 26: 306–8.
11.
KDOQI Clinical practice guidelines and clinical practice recommendations.2006 update.Am J Kidney Dis2006; 48(Suppl 1): S91–175.
12.
LoW.K., BargmanJ.M., BurkartJ., KredietR.T., PollockC., KawanishiH.Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis.Perit Dial Int2006; 26: 520–2.
13.
PlumJ., GentileS., VergerC., BrunkhorstR., BahnerU., FallerB.Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.Am J Kidney Dis2002; 39: 862–71.
14.
WolfsonM., PirainoB., HamburgerR.J., MortonA.R.A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis.Am J Kidney Dis2002; 40: 1055–65.
15.
DaviesS.J., WoodrowG., DonovanK., PlumJ., WilliamsP., JohanssonA.C.Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial.J Am Soc Nephrol2003; 14: 2338–44.
16.
KoningsC.J., KoomanJ.P., SchonckM., GladziwaU., WirtzJ., van den Wall BakeA.W.Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.Kidney Int2003; 63: 1556–63.
17.
DallasF., JenkinsS.B., WilkieM.E.Enhanced ultrafiltration using 7.5% icodextrin/1.36% glucose combination dialysate: a pilot study.Perit Dial Int2004; 24: 542–6.
18.
JenkinsS.B., WilkieM.E.An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone.Perit Dial Int2003; 23: 475–80.
BrandesJ.C., PackardW.J., WattersS.K., FritscheC.Optimization of dialysate flow and mass transfer during automated peritoneal dialysis.Am J Kidney Dis1995; 25: 603–10.
21.
ImholzA.L.T., KoomenG.C.M., VoornW.J., StruijkD.G., AriszL., KredietR.T.Day-to-day variability of fluid and solute transport in upright and recumbent positions during CAPD.Nephrol Dial Transplant1998; 13: 146–53.
22.
FischbachM., DheuC., HelmsP., TerzicJ., MichallatA.C., LaugelV.The influence of peritoneal surface area on dialysis adequacy.Perit Dial Int2005; 25(Suppl 3): S137–40.
23.
WangT., ChengH., HeimbürgerO., BergströmJ., LindholmB.High peritoneal residual volume decreases the efficiency of peritoneal dialysis.Kidney Int1999; 55: 2040–8.
24.
TjiongH.L., van den BergJ.W., WattimenaJ.L., RietveldT., van DijkL.J., van der WielA.M.Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis.J Am Soc Nephrol2005; 16: 1486–93.
25.
WestraW.M., KoppleJ.D., KredietR.T., AppellM., MehrotraR.Dietary protein requirements and dialysate protein losses in chronic peritoneal dialysis patients.Perit Dial Int2007; 27: 192–5.
26.
WangT., HeimbürgerO., WaniewskiJ., BergströmJ., LindholmB.Increased peritoneal permeability is associated with decreased fluid and small solute removal and higher mortality in CAPD patients.Nephrol Dial Transplant1998; 13: 1242–9.
27.
KangD.H., YoonK.I., ChoiK.B., LeeR., LeeH.Y., HanD.S.Relationship of peritoneal membrane transport character is tics to the nutritional status in C APD patients.Nephrol Dial Transplant1999; 14: 1715–22.
28.
CooperS., IliescuE.A., MortonA.R.The relationship between dialysate protein loss and membrane transport status in peritoneal dialysis patients.Adv Perit Dial2001; 17: 244–7.
29.
ChungS.H., HeimbürgerO., StenvinkelP., WangT., LindholmB.Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients.Perit Dial Int2003; 23: 174–83.
30.
KathuriaP., MooreH.L., TwardowskiZ.J., GoelS., NolphK.D.Effect of dialysis modality and membrane transport characteristics on dialysate protein losses of patients on peritoneal dialysis.Perit Dial Int1997; 17: 449–54.
31.
BurkartJ.M.Effect of peritoneal dialysis prescription and peritoneal membrane transport characteristics on nutritional status.Perit Dial Int1995; 15(5 Suppl): S20–35.
SchaeferF., KlausG., MehlsO.Peritoneal transport properties and dialysis dose affect growth and nutritional status in children on chronic peritoneal dialysis.J Am Soc Nephrol1999; 10: 1786–92.
34.
HeafJ.G., SaracS., AfzalS.A high peritoneal large pore fluid flux causes hypoalbuminemia and is a risk factor for death in peritoneal dialysis patients.Nephrol Dial Transplant2005; 20: 2194–201.
35.
BroS., BjornerJ.B., Tofte-JensenP., KlemS., AlmtoftB., DanielsenH.A prospective, randomized multicenter study comparing APD and CAPD treatment.Perit Dial Int1999; 19: 526–33.
36.
de FijterC.W.H., OeL.P., NautaJ.J.P., van der MeulenJ., VerbrughH.A., VerhoefJ.Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis.Ann Intern Med1994; 120: 264–71.
37.
BrownE.A., DaviesS.J., RutherfordP., MeeusF., BorrásM., RiegelW.Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study.J Am Soc Nephrol2003; 14: 2948–57.
38.
PaniaguaR., AmatoD., VoneshE., Correa-RotterR., RamosA., MoránJ.Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis. ADEMEX, a prospective, randomized, controlled trial.J Am Soc Nephrol2002; 13: 1307–20.
39.
LoW.K., HoY.W., LiC.S., WongK.S., ChanT.M., YuA.W.Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized, prospective study.Kidney Int2003; 64: 649–56.
40.
VychytilA., LilajT., SchneiderB., HorlW.H., Haag-WeberM.Tidal peritoneal dialysis for home treated patients. Should it be preferred?Am J Kidney Dis1999; 33: 334–43.
41.
Diaz-BuxoJ.A.What is the role of automated peritoneal dialysis and continuous flow peritoneal dialysis?Contrib Nephrol2003; 140: 264–71.
42.
FreidaP., IssadB.Continuous flow peritoneal dialysis: assessment of fluid and solute removal in a high-flow model of “fresh dialysate single pass.”Perit Dial Int2003; 23: 348–55.
